Market News & Analysis
Market Brief: Good (and Bad) Signals Out of China Ahead of Tomorrow’s Trade Talks
Matt Weller, CFA, CMT October 9, 2019 9:03 PM
- Risk appetite was boosted today by headlines that China would purchase an extra $10MM tons of US soybeans in a possible sign of goodwill ahead of trade talks kicking off tomorrow. That said, late headlines that Beijing was “lowering expectations” for the talks took stocks off their highest intraday levels heading into the close.
- FX: The euro was the strongest major currency, though it held below the widely-watched 1.10 level. The safe haven Swiss franc and Japanese yen were the weakest major currencies on the day.
- US data: JOLTS job openings fell to their lowest level since March 2018, though they remain historically strong. The FOMC minutes showed that “several” participants favored keeping interest rates steady before ultimately aligning with the majority in favor of a rate cut. That said, a run of weak economic data over the last couple weeks may have them reconsidering the need for further rate cuts.
- Commodities: Gold ticked higher on the day, while oil finished essentially flat despite a larger-than-expected inventory buildup (after trading higher earlier in the day).
- US indices closed solidly higher on the day to erase most of yesterday’s loss. The tech-heavy Nasdaq led the way higher.
- All eleven sectors rose on the day, led by Technology (XLK). REITs (XLRE) rose the least.
- Stocks on the move:
- American Airlines (AAL) rallied 3% despite announcing that it expects Boeing’s 737 MAX jet would remain grounded until January.
- Johnson and Johnson (JNJ) dropped -2% after a court ruled the company must pay $8B in damages after the company’s drug Risperdal led to enlarged breast tissue.
From time to time, GAIN Capital Limited’s (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.